HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Abstract
Septic shock is the commonest cause of death in intensive care units. Although sepsis usually produces a low systemic vascular resistance and elevated cardiac output, strong evidence (decreased ejection fraction and reduced response to fluid administration) suggests that the ventricular myocardium is depressed and the ventricle dilated. In survivors, these abnormalities are reversible. Failure to develop ventricular dilatation in nonsurvivors suggests that dilatation is a compensatory mechanism needed to maintain adequate cardiac output. With a canine model of septic shock that is very similar to human sepsis, myocardial depression was confirmed using load-independent measures of ventricular performance. Endotoxin administration to humans simulates the qualitative, cardiovascular abnormalities of sepsis. The pathogenesis of septic shock is extraordinarily complex. Diverse microorganisms can generate toxins, stimulating release of potent mediators that act on vasculature and myocardium. A circulating myocardial depressant substance has been closely associated with the myocardial depression of human septic shock. Therapy has emphasized early use of antibiotics, critical care monitoring, aggressive volume resuscitation, and, if shock continues, use of inotropic agents and vasopressors. Pharmacologic or immunologic antagonism of endotoxin or other mediators may prove to enhance survival in this highly lethal syndrome.
AuthorsJ E Parrillo, M M Parker, C Natanson, A F Suffredini, R L Danner, R E Cunnion, F P Ognibene
JournalAnnals of internal medicine (Ann Intern Med) Vol. 113 Issue 3 Pg. 227-42 (Aug 01 1990) ISSN: 0003-4819 [Print] United States
PMID2197912 (Publication Type: Consensus Development Conference, Consensus Development Conference, NIH, Journal Article, Review)
Chemical References
  • Endotoxins
Topics
  • Animals
  • Cardiovascular System (physiopathology)
  • Dogs
  • Endotoxins (physiology)
  • Humans
  • Shock, Septic (etiology, physiopathology, therapy)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: